The Indiana Health Information Exchange (IHIE) announced that its Quality Health First Program has enrolled more than 1,500 physicians in more than 50 communities
The Indiana Health Information Exchange (IHIE) announced that its Quality Health First Program has enrolled more than 1,500 physicians in more than 50 communities throughout Indiana to help improve screenings rates and to support the management of medical conditions such as diabetes, heart disease, asthma and breast cancer for nearly 1 million patients.
Patients needing these and other interventions are flagged in reports to their primary care physician, enabling the physician to make care decisions before, during and after patient visits. Participation is open to any primary care practice in Indiana, regardless of its size or number of physicians, and is not restrictive to practices that do not use electronic health records.
The reports are based on more than 3 billion pieces of clinical information, along with claims information. The program allows physicians to review and verify the data, and to reconcile missing or inaccurate data.
For care provided in 2009, Anthem Blue Cross Blue Shield of Indiana awarded bonus payments totaling $3.4 million to participating primary care physicians in Indiana based on improvements in overall patient health. The amount of bonus payments from Anthem for care delivered by participating physicians in 2010 is expected to exceed that amount.
In addition to Anthem, United Healthcare and Unified Group Services, Medicare and Medicaid all participate in the program.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Mental Health Comorbidities Affect Uptravi Prescribing for PAH
October 23rd 2024New real-world data suggest that physicians are cautious about prescribing the prostacyclin-receptor agonist Uptravi (selexipag) to pulmonary arterial hypertension (PAH) patients with mental health conditions when evidence suggests that it is best to take a proactive approach to treating PAH.
Read More
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
High-Dose Eylea Shows Unique Properties in nAMD and DME | AAO 2024
October 22nd 2024A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks to as long as 20 weeks for neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME).
Read More